HCA Healthcare, Inc. (NYSE:HCA) Shares Sold by ERn Financial LLC

ERn Financial LLC lowered its holdings in HCA Healthcare, Inc. (NYSE:HCAFree Report) by 3.0% during the third quarter, according to the company in its most recent filing with the SEC. The fund owned 1,814 shares of the company’s stock after selling 57 shares during the quarter. ERn Financial LLC’s holdings in HCA Healthcare were worth $737,000 at the end of the most recent reporting period.

Other institutional investors have also recently added to or reduced their stakes in the company. CreativeOne Wealth LLC acquired a new position in shares of HCA Healthcare in the 1st quarter valued at $231,000. New Mexico Educational Retirement Board grew its stake in HCA Healthcare by 29.9% during the 1st quarter. New Mexico Educational Retirement Board now owns 13,900 shares of the company’s stock worth $4,636,000 after buying an additional 3,200 shares during the last quarter. Kingswood Wealth Advisors LLC acquired a new stake in shares of HCA Healthcare in the first quarter valued at approximately $566,000. Bessemer Group Inc. raised its position in HCA Healthcare by 51.2% in the 1st quarter. Bessemer Group Inc. now owns 7,629 shares of the company’s stock valued at $2,543,000 after purchasing an additional 2,584 shares during the last quarter. Finally, Empowered Funds LLC grew its position in HCA Healthcare by 54.3% during the 1st quarter. Empowered Funds LLC now owns 13,910 shares of the company’s stock worth $4,639,000 after purchasing an additional 4,893 shares during the last quarter. Hedge funds and other institutional investors own 62.73% of the company’s stock.

Insider Buying and Selling at HCA Healthcare

In related news, EVP Michael S. Cuffe sold 8,358 shares of the business’s stock in a transaction that occurred on Thursday, September 12th. The shares were sold at an average price of $385.42, for a total value of $3,221,340.36. Following the completion of the sale, the executive vice president now directly owns 29,678 shares in the company, valued at approximately $11,438,494.76. The trade was a 0.00 % decrease in their ownership of the stock. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through the SEC website. In other news, SVP Kathryn A. Torres sold 1,857 shares of the firm’s stock in a transaction dated Thursday, July 25th. The stock was sold at an average price of $355.05, for a total value of $659,327.85. Following the transaction, the senior vice president now directly owns 17,755 shares in the company, valued at $6,303,912.75. This trade represents a 0.00 % decrease in their position. The transaction was disclosed in a document filed with the SEC, which is available through this hyperlink. Also, EVP Michael S. Cuffe sold 8,358 shares of the stock in a transaction that occurred on Thursday, September 12th. The stock was sold at an average price of $385.42, for a total transaction of $3,221,340.36. Following the sale, the executive vice president now directly owns 29,678 shares of the company’s stock, valued at approximately $11,438,494.76. This trade represents a 0.00 % decrease in their position. The disclosure for this sale can be found here. Insiders sold 17,202 shares of company stock worth $6,407,273 in the last 90 days. 1.60% of the stock is owned by company insiders.

HCA Healthcare Trading Up 1.4 %

Shares of HCA Healthcare stock opened at $401.26 on Wednesday. The business has a 50 day moving average price of $389.03 and a 200 day moving average price of $348.47. The company has a market capitalization of $105.10 billion, a P/E ratio of 20.00, a P/E/G ratio of 1.44 and a beta of 1.67. The company has a debt-to-equity ratio of 27.11, a current ratio of 1.06 and a quick ratio of 0.94. HCA Healthcare, Inc. has a 1 year low of $215.96 and a 1 year high of $411.87.

HCA Healthcare (NYSE:HCAGet Free Report) last posted its quarterly earnings data on Tuesday, July 23rd. The company reported $5.50 EPS for the quarter, topping analysts’ consensus estimates of $4.97 by $0.53. HCA Healthcare had a return on equity of 553.13% and a net margin of 8.40%. The firm had revenue of $17.49 billion during the quarter, compared to analysts’ expectations of $17.05 billion. During the same quarter last year, the business posted $4.29 EPS. The firm’s quarterly revenue was up 10.3% compared to the same quarter last year. Sell-side analysts anticipate that HCA Healthcare, Inc. will post 22.51 EPS for the current fiscal year.

HCA Healthcare Announces Dividend

The firm also recently announced a quarterly dividend, which was paid on Monday, September 30th. Investors of record on Monday, September 16th were paid a $0.66 dividend. The ex-dividend date of this dividend was Monday, September 16th. This represents a $2.64 annualized dividend and a yield of 0.66%. HCA Healthcare’s payout ratio is currently 13.16%.

Wall Street Analysts Forecast Growth

A number of equities analysts recently issued reports on the company. StockNews.com raised HCA Healthcare from a “buy” rating to a “strong-buy” rating in a report on Monday, July 1st. Wolfe Research upgraded HCA Healthcare to a “strong-buy” rating in a research note on Thursday, August 29th. Wells Fargo & Company upped their price objective on shares of HCA Healthcare from $315.00 to $365.00 and gave the stock an “equal weight” rating in a research report on Tuesday, July 30th. Truist Financial increased their price target on shares of HCA Healthcare from $390.00 to $430.00 and gave the stock a “buy” rating in a report on Monday, August 19th. Finally, UBS Group boosted their target price on HCA Healthcare from $405.00 to $438.00 and gave the stock a “buy” rating in a research report on Wednesday, August 14th. Five research analysts have rated the stock with a hold rating, fourteen have given a buy rating and four have issued a strong buy rating to the stock. According to data from MarketBeat, HCA Healthcare currently has an average rating of “Moderate Buy” and an average price target of $365.65.

Get Our Latest Stock Report on HCA

About HCA Healthcare

(Free Report)

HCA Healthcare, Inc, through its subsidiaries, owns and operates hospitals and related healthcare entities in the United States. It operates general and acute care hospitals that offers medical and surgical services, including inpatient care, intensive care, cardiac care, diagnostic, and emergency services; and outpatient services, such as outpatient surgery, laboratory, radiology, respiratory therapy, cardiology, and physical therapy.

Further Reading

Institutional Ownership by Quarter for HCA Healthcare (NYSE:HCA)

Receive News & Ratings for HCA Healthcare Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for HCA Healthcare and related companies with MarketBeat.com's FREE daily email newsletter.